S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
NASDAQ:TERN

Terns Pharmaceuticals (TERN) Stock Price, News & Analysis

$5.14
-0.08 (-1.53%)
(As of 04/12/2024 ET)
Today's Range
$5.01
$5.29
50-Day Range
$5.05
$8.19
52-Week Range
$3.26
$14.04
Volume
726,672 shs
Average Volume
882,928 shs
Market Capitalization
$332.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.94

Terns Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
190.6% Upside
$14.94 Price Target
Short Interest
Bearish
10.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.95
Upright™ Environmental Score
News Sentiment
0.99mentions of Terns Pharmaceuticals in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$2.12 M Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.46) to ($1.51) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.95 out of 5 stars

Medical Sector

583rd out of 2,784 stocks

Pharmaceutical Preparations Industry

229th out of 1,293 stocks

TERN stock logo

About Terns Pharmaceuticals Stock (NASDAQ:TERN)

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

TERN Stock Price History

TERN Stock News Headlines

The next Nvidia (and it’s not Microsoft or Facebook)
Imagine buying Bitcoin at $1,000. That would have been the trade of the decade... right? Well, I think there's an even bigger play to be made in the A.I. space.
The next Nvidia (and it’s not Microsoft or Facebook)
Imagine buying Bitcoin at $1,000. That would have been the trade of the decade... right? Well, I think there's an even bigger play to be made in the A.I. space.
TERN Apr 2024 15.000 call
Terns Pharma Names Amy Burroughs as CEO
Terns Pharmaceuticals Appoints Amy Burroughs As CEO
See More Headlines
Receive TERN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Terns Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/14/2024
Today
4/12/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TERN
Fax
N/A
Employees
66
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.94
High Stock Price Target
$23.00
Low Stock Price Target
$5.50
Potential Upside/Downside
+190.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$-90,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1 million
Book Value
$4.13 per share

Miscellaneous

Free Float
53,403,000
Market Cap
$332.30 million
Optionable
Not Optionable
Beta
-0.63
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Erin Quirk M.D. (Age 53)
    President & Head of Research & Development
    Comp: $808.16k
  • Mr. Seokho Yoon Esq. (Age 46)
    COO, General Counsel & Secretary
    Comp: $712.84k
  • Ms. Amy L. Burroughs M.B.A. (Age 53)
    CEO & Director
  • Dr. Mark Joseph Vignola Ph.D. (Age 46)
    CFO & Treasurer
    Comp: $402.15k
  • Dr. Jeffrey R. Jasper Ph.D.
    Senior VP & Head of Research
  • Dr. Emil T. Kuriakose M.D. (Age 44)
    Chief Medical Officer of Oncology

TERN Stock Analysis - Frequently Asked Questions

Should I buy or sell Terns Pharmaceuticals stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Terns Pharmaceuticals in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TERN shares.
View TERN analyst ratings
or view top-rated stocks.

What is Terns Pharmaceuticals' stock price target for 2024?

8 Wall Street research analysts have issued 12-month price targets for Terns Pharmaceuticals' stock. Their TERN share price targets range from $5.50 to $23.00. On average, they predict the company's share price to reach $14.94 in the next twelve months. This suggests a possible upside of 190.6% from the stock's current price.
View analysts price targets for TERN
or view top-rated stocks among Wall Street analysts.

How have TERN shares performed in 2024?

Terns Pharmaceuticals' stock was trading at $6.49 at the beginning of the year. Since then, TERN stock has decreased by 20.8% and is now trading at $5.14.
View the best growth stocks for 2024 here
.

When is Terns Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our TERN earnings forecast
.

How were Terns Pharmaceuticals' earnings last quarter?

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) announced its quarterly earnings results on Thursday, March, 14th. The company reported ($0.29) EPS for the quarter, hitting the consensus estimate of ($0.29).

When did Terns Pharmaceuticals IPO?

Terns Pharmaceuticals (TERN) raised $101 million in an initial public offering (IPO) on Friday, February 5th 2021. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO.

How do I buy shares of Terns Pharmaceuticals?

Shares of TERN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TERN) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners